Equities research analysts forecast that Alcentra Capital Corp (NASDAQ:ABDC) will announce earnings of $0.21 per share for the current quarter, according to Zacks Investment Research. Four analysts have provided estimates for Alcentra Capital’s earnings, with the highest EPS estimate coming in at $0.22 and the lowest estimate coming in at $0.20. Alcentra Capital posted earnings per share of $0.28 during the same quarter last year, which would indicate a negative year-over-year growth rate of 25%. The company is scheduled to issue its next earnings report on Wednesday, March 13th.
On average, analysts expect that Alcentra Capital will report full-year earnings of $0.94 per share for the current financial year, with EPS estimates ranging from $0.92 to $0.97. For the next financial year, analysts forecast that the company will post earnings of $0.80 per share, with EPS estimates ranging from $0.74 to $0.85. Zacks Investment Research’s EPS averages are a mean average based on a survey of sell-side research firms that cover Alcentra Capital.
Alcentra Capital (NASDAQ:ABDC) last issued its quarterly earnings results on Monday, November 5th. The asset manager reported $0.22 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.21 by $0.01. The firm had revenue of $6.55 million for the quarter, compared to analysts’ expectations of $6.61 million. Alcentra Capital had a positive return on equity of 10.10% and a negative net margin of 43.78%.
Separately, ValuEngine raised Alcentra Capital from a “sell” rating to a “hold” rating in a research note on Tuesday, October 23rd. Two investment analysts have rated the stock with a sell rating and three have issued a hold rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average price target of $7.00.
A number of large investors have recently added to or reduced their stakes in the business. Belpointe Asset Management LLC purchased a new position in Alcentra Capital during the 2nd quarter valued at about $107,000. Bank of New York Mellon Corp grew its stake in Alcentra Capital by 17.6% during the 2nd quarter. Bank of New York Mellon Corp now owns 629,022 shares of the asset manager’s stock valued at $4,019,000 after acquiring an additional 94,111 shares in the last quarter. Finally, Salzhauer Michael grew its stake in Alcentra Capital by 100.8% during the 2nd quarter. Salzhauer Michael now owns 247,178 shares of the asset manager’s stock valued at $910,000 after acquiring an additional 124,057 shares in the last quarter. 32.65% of the stock is currently owned by institutional investors.
ABDC traded up $0.52 during trading on Tuesday, reaching $6.37. The company had a trading volume of 222,377 shares, compared to its average volume of 69,229. The stock has a market capitalization of $78.74 million, a P/E ratio of 4.83 and a beta of 0.59. Alcentra Capital has a 12-month low of $5.58 and a 12-month high of $9.01.
About Alcentra Capital
Alcentra Capital Corporation is a business development company specializing in investments in lower middle-market companies. The fund seeks to invest in healthcare, business services, defense, government services, telecom and technology, media, infrastructure maintenance and logistics, and oil and gas services sector.
Recommended Story: How mutual funds make money
Get a free copy of the Zacks research report on Alcentra Capital (ABDC)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Alcentra Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital and related companies with MarketBeat.com's FREE daily email newsletter.